Filing Details

Accession Number:
0001181431-14-039790
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-29 17:13:10
Reporting Period:
2014-12-23
Filing Date:
2014-12-29
Accepted Time:
2014-12-29 17:13:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219855 James M Barrett 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-23 10,000 $0.00 0 No 4 J Indirect See Note 3
Common Stock Acquisiton 2014-12-23 296 $0.00 296 No 4 J Direct
Common Stock Acquisiton 2014-12-23 296 $0.00 296 No 4 J Indirect See Note 6
Common Stock Acquisiton 2014-12-23 1,972 $0.00 1,972 No 4 J Indirect See Note 8
Common Stock Disposition 2014-12-26 296 $21.54 0 No 4 S Direct
Common Stock Disposition 2014-12-26 296 $21.54 0 No 4 S Indirect See Note 6
Common Stock Disposition 2014-12-26 1,972 $21.28 0 No 4 S Indirect See Note 8
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect See Note 3
No 4 J Direct
No 4 J Indirect See Note 6
No 4 J Indirect See Note 8
No 4 S Direct
No 4 S Indirect See Note 6
No 4 S Indirect See Note 8
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,619,734 Indirect See Note 1
Footnotes
  1. The Reporting Person is a manager of NEA 12 GP, LLC, ("NEA 12 GP") which is the sole general partner of NEA Partners 12, Limited Partnership ("NEA Partners 12"). NEA Partners 12 is the sole general partner of New Enterprise Associates 12, Limited Partnership ("NEA 12"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 12 in which the Reporting Person has no pecuniary interest.
  2. NEA Partners 12 made a pro rata distribution for no consideration of an aggregate of 10,000 shares of Common Stock of the Issuer to its limited partners on December 23, 2014.
  3. The Reporting Person is a manager of NEA 12 GP, the sole general partner of NEA Partners 12. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA Partners 12 in which the Reporting Person has no pecuniary interest.
  4. M. James Barrett and April Barrett received 296 shares of Common Stock of the Issuer in the distribution by NEA Partners 12 on December 23, 2014.
  5. The Barrett 2006 Family Trust received 296 shares of Common Stock of the Issuer in the distribution by NEA Partners 12 on December 23, 2014.
  6. The securities are directly held by the Barrett 2006 Family Trust. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by the Barrett 2006 Family Trust in which the Reporting Person has no pecuniary interest.
  7. New Enterprise Associates, LLC ("NEA LLC") received 1,972 shares of Common Stock of the Issuer in the distribution by NEA Partners 12 on December 23, 2014.
  8. The Reporting Person is a member of the Board of Directors of NEA LLC, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by NEA LLC in which the Reporting Person has no pecuniary interest.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (9) to this Form 4.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.92 to $21.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (10) to this Form 4.